Clinical Trials Directory

Trials / Completed

CompletedNCT04888689

Holter of Movement in Patients with Multiple Sclerosis in Controlled Environment.

Holter of Movement in Patients with Multiple Sclerosis. Acti-SEP Study: Controlled Environment.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Laurent Servais · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

ActiSEP is a multicentric academic study. Ambulant patients with multiple sclerosis may be included on a voluntary basis. We plan to include a group of approximately 20 patients with MS. This study include a unique evaluation in the laboratory of analysis of human movement. A set of tasks will be performed by patients wearing of two magneto-inertial sensors.

Conditions

Interventions

TypeNameDescription
DEVICEActimyo°Actimyo° is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle.
DEVICEIMUIMU is a portable system of miniaturized inertial sensors for objective, instrumental, ambulatory, and validated analysis of normal and pathological human gait. Each miniaturized inertial sensor (2 cm × 0.7 cm × 0.5 cm) includes a triaxial accelerometer and a triaxial gyroscope. These four inertial sensors are connected to a box by wires and are numbered 1 to 4. They must be attached - using adhesive tapes - on the participant's shoes.

Timeline

Start date
2021-02-04
Primary completion
2021-09-30
Completion
2021-09-30
First posted
2021-05-17
Last updated
2025-02-12

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04888689. Inclusion in this directory is not an endorsement.